EYLER CHARLES R 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Jul 24, 2017
Insider Transaction Report
Form 4
EYLER CHARLES R
SR. VP-FINANCE & TREASURER
Transactions
- Sale
COMMON STOCK
2017-07-20$95.15/sh−662$62,991→ 30,018 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in two transactions with one transaction pricing at $95.151 and the other transaction pricing at $95.701. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote.